Press Room

BOSTON – Transcranial Magnetic Stimulation (TMS) can be a safe, effective nonpharmacological intervention that can treat older adults who suffer from geriatric depression even when they also have other chronic health conditions, such as dementia or Alzheimer’s disease.

BOSTON – A new study published today in the Journal of Gerontology: Medical Sciences found that multifaceted interventions, particularly cohorting of residents, in addition to adherence to proper infection control procedures, can reduce COVID-19 infections, even in facilities with high percentages of high-risk residents. Earlier studies found that high-risk nursing home residents, especially those who were Black or were suffering from dementia, tended to have higher infection rates for COVID-19.

Healthy Longevity Initiative Grant Awarded to Study the Mycobiome as a Novel Class of Probiotics to Target Inflammaging

BOSTON – Solarea Bio, a biotechnology company in Cambridge, Mass., and leading researchers at Harvard Medical School affiliated Hebrew SeniorLife, New England’s largest nonprofit provider of senior health care and living communities, are co-investigators on a competitive research grant from the U.S. National Academy of Medicine’s Healthy Longevity Initiative.

Results Suggest That Delirium Has Substantial Public Health Implications

BOSTON – Results of a study published today in JAMA Surgery reveal the impact post-operative delirium has on health care costs in the U.S. Data from the study shows that if delirium were prevented or made less severe for patients, it could reduce health care costs by $33 billion per year, that is, $44,300 per patient per year. Severe delirium resulted in an additional $56,500 per patient per year, as compared to routine health care costs for older post-operative patients.